rs1553248641
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_006147.4(IRF6):c.25C>T(p.Arg9Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R9Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006147.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant popliteal pterygium syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- IRF6-related conditionInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- van der Woude syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- popliteal pterygium syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- van der Woude syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- orofacial cleft 6, susceptibility toInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458682Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 725400 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Van der Woude syndrome;C0265259:Popliteal pterygium syndrome;C1837213:Orofacial cleft 6, susceptibility to Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 9 of the IRF6 protein (p.Arg9Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Van der Woude syndrome (PMID: 15472655, 19449419, 31468312; internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 449039). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt IRF6 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg9 amino acid residue in IRF6. Other variant(s) that disrupt this residue have been observed in individuals with IRF6-related conditions (PMID: 19282774), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Van der Woude syndrome 1 Pathogenic:1
- -
not provided Pathogenic:1
The R9W variant in the IRF6 gene has previously been reported in association with van der Woude syndrome (Matsuzaka et al., 2004; Jehee et al., 2009). This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R9W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and located within the DNA-binding domain (Little et al., 2009). In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available evidence, R9W is a strong candidate for a pathogenic variant. However, the possibility it may be a rare benign variant cannot be excluded. -
IRF6-related condition Pathogenic:1
The IRF6 c.25C>T variant is predicted to result in the amino acid substitution p.Arg9Trp. This variant has been reported in individuals with Van der Woude syndrome (Matsuzawa et al. 2004. PubMed ID: 15472655; Jehee et al. 2009. PubMed ID: 19449419). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at